Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Study ID: NCT06998095
Start Date: 2026-11-28
End Date: 2029-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

210

Intervention / Treatment
Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations

Study ID: NCT07464327
Start Date: 2026-03-31
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

450

Intervention / Treatment

HS-20093

Docetaxel

Sponsor

Hansoh BioMedical R&D Company

Source: clinicaltrials.gov

Share:
Add to list

Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence

Study ID: NCT07477028
Start Date: 2026-09-01
End Date: 2035-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment
Sponsor

Noah Tech, Corp.

Source: clinicaltrials.gov

Share:
Add to list

Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue

Study ID: NCT07489833
Start Date: 2026-04-20
End Date: 2029-02-28
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment
Sponsor

Chang Gung Memorial Hospital

Source: clinicaltrials.gov

Share:
Add to list

AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

Study ID: NCT05432765
Start Date: 2026-12
End Date: 2031-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

34

Intervention / Treatment

Phenotypic Personalized Medicine Dosing

Standard of Care Dosing

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Study ID: NCT07281547
Start Date: 2026-08-12
End Date: 2027-06-11
Study Type

Interventional

Study Phase

Phase4

No. of Participants

25

Intervention / Treatment

Biospecimen Collection

Low-Dose Aspirin

Patient Observation

Administration Questionnaire

Ultrasound Imaging

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Accelerated vs Standard Approach to Continuous Veno-venous Hemodiafiltration Post-hemoperfusion (ASAP) in Severe Acute Diquat Poisoning

Study ID: NCT06966765
Start Date: 2027-01-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

267

Intervention / Treatment

Continuous Veno-Venous Hemodiafiltration

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Source: clinicaltrials.gov

Share:
Add to list

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Study ID: NCT07210632
Start Date: 2026-03-30
End Date: 2031-03-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

38

Intervention / Treatment

Nivolumab

Nivolumab-IRDye800

Sponsor

Eben Rosenthal

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke

Study ID: NCT07483281
Start Date: 2026-05-01
End Date: 2028-06-18
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

220

Intervention / Treatment

Human Urinary Kallidinogenase

Clinical Routine Treatment

Sponsor

China-Japan Union Hospital

Source: clinicaltrials.gov

Share:
Add to list

Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy

Study ID: NCT07021430
Start Date: 2026-04
End Date: 2028-04
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

300

Intervention / Treatment

Dihydroartemisinin Piperaquine

Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list